Supplementary Material for: Pembrolizumab induced rhabdomyolysis in a clear cell renal cell carcinoma patient: a case report

Supplementary Material for: Pembrolizumab induced rhabdomyolysis in a clear cell renal cell carcinoma patient: a case report

Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma (RCC) yet has many possible immune related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: M., Altermanini, K., Ali, W., Alwassiti, S., Almohtasib, N.E., Omar, A., Zafar
Format: Dataset
Sprache:eng
Schlagworte:
Medicine
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma (RCC) yet has many possible immune related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient treated with Pembrolizumab. The case was complicated with acute kidney injury and severe hypothyroidism, which we can be attributed to Pembrolizumab.
DOI:10.6084/m9.figshare.23978175